Incyte, Eli Lilly present results from Phase 3 BRAVE-AA-PEDS study
Late-breaking results from Eli Lilly and Company (LLY) and Incyte (INCY) found adolescent patients with severe alopecia areata, AA, treated ...
LifeMD Q4 2024 Earnings Preview
LifeMD (NASDAQ:LFMD) is scheduled to announce Q4 earnings results on Monday, March 10th, after market close. The consensus EPS Estimate is $0.14 (-6.7% Y/Y) and the consensus Revenue Estimate is ...